The role of PML in hematopoietic and leukemic stem cell maintenance

Fumio Nakahara1, Cary N Weiss, Keisuke Ito

  • 1Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Departments of Cell Biology and Medicine, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.

Insights

The tumor suppressor promyelocytic leukemia (PML) protein is crucial for maintaining normal hematopoietic stem cells by regulating fatty acid oxidation. Targeting PML pathways offers new therapeutic strategies for leukemia and other stem cell-related diseases.

Area of Science:

  • Molecular Biology
  • Stem Cell Biology
  • Oncology

Background:

  • The promyelocytic leukemia (PML) tumor suppressor was initially identified in acute promyelocytic leukemia.
  • PML plays diverse roles in DNA damage response, apoptosis, senescence, and angiogenesis.
  • PML is increasingly recognized as a regulator of metabolic pathways in stem cell compartments.

Purpose of the Study:

  • To review research on PML and its associated pathways in stem cell biology.
  • To highlight the role of PML in regulating metabolic pathways essential for stem cell maintenance.
  • To discuss the therapeutic potential of targeting PML-associated pathways.

Main Methods:

  • Literature review of PML research in stem cell biology and leukemia.
  • Analysis of PML's role in metabolic regulation, specifically fatty acid oxidation.
  • Examination of therapeutic strategies involving PML-associated pathways.

Main Results:

  • PML is essential for the maintenance of normal hematopoietic stem cells.
  • PML regulates fatty acid oxidation, a key process for hematopoietic stem cell maintenance.
  • PML is also critical for the maintenance of leukemia-initiating cells.

Conclusions:

  • PML is a key regulator of stem cell maintenance and metabolism.
  • Targeting PML-associated pathways, such as fatty acid oxidation, presents therapeutic opportunities.
  • Arsenic trioxide shows promise for treating chronic myeloid leukemia by targeting PML pathways.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K